Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

247.98
BATS BZX Real-Time Price
As of 10:35am ET
 +0.82 / +0.33%
Today’s Change
184.50
Today|||52-Week Range
301.32
+18.08%
Year-to-Date
AGN Regular Dividend: AGN will begin trading ex-dividend on 02/24/17 with a $0.70 dividend payable to shareholders of record as of 02/28/17.

Today’s Trading

Previous close247.16
Today’s open247.26
Day’s range246.91 - 249.00
Volume34,926
Average volume (3 months)4,784,227
Market cap$92.7B
Dividend yield1.13%
Data as of 10:35am ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.68%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.97+0.81%
BMYBristol-Myers Squibb+0.77+1.40%
LLYEli Lilly and Co+0.57+0.71%
ABBVAbbVie-0.08-0.13%
Data as of 10:35am ET, 02/22/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.40
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs